Biogen (BIIB)

Sales/Maturities of Investments

$56.60M

TTM · Period ending: · USD

BIIB logo

BIIB Sales/Maturities of Investments

Latest reported$56.60M
BIIB TTM Sales/Maturities of Investments ($0.00 → $56.60M)
High-resolution chart · PNG

BIIB sales/maturities of investments history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Biogen Sales/Maturities of Investments — Trailing twelve months (TTM) (USD)
Period endingSales/Maturities of Investments (USD)
56,600,000
682,300,000
56,600,000
16,000,000
-15,800,000
495,900,000
551,500,000
605,500,000
6,282,300,000
7,903,600,000
8,288,500,000
8,841,400,000
4,783,000,000
4,558,200,000
4,661,300,000
5,474,600,000
4,406,800,000
3,132,100,000
3,498,900,000
4,252,400,000
5,037,800,000
5,894,900,000
7,374,300,000
7,383,899,999
6,801,199,999
7,386,899,999
6,486,299,999
5,522,600,000
5,936,500,000
6,594,000,000
9,173,700,000
9,088,000,000
8,784,100,000
7,750,500,000
5,565,900,000
6,665,700,000
8,139,800,000
8,082,100,000
7,378,900,000
5,885,426,000
5,911,083,000
4,870,537,000
4,063,000,000
4,139,426,000
2,376,915,000
2,334,974,000
2,718,923,000
2,107,705,000
2,102,870,000
1,618,058,000
5,190,052,000
5,871,453,000
5,740,392,000
6,264,688,000
2,759,616,000
2,715,075,000
2,532,253,000
2,314,509,000
2,278,158,000
1,654,795,000
1,835,987,000
2,427,470,000
2,668,694,000
3,489,099,000
3,697,810,000
3,304,465,000
3,332,829,000
3,140,088,000
3,186,658,000
3,080,759,000
2,941,060,000
2,586,514,000
2,205,375,000
3,368,076,000
3,253,779,000
3,121,372,000
3,204,450,000
2,232,937,000
1,787,139,000
1,713,756,000
1,528,809,000
1,785,172,000
1,782,134,000
1,799,806,000
1,925,425,000
1,853,332,000
3,200,386,000
3,635,959,000
3,427,800,000
2,699,302,000
1,118,775,000
524,030,000
445,169,000
426,242,000
405,301,000
385,273,000
393,361,000
464,453,000
770,426,000
786,488,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.